31 related articles for article (PubMed ID: 8357429)
1. Is the bleeding time prolonged in oral anticoagulant treatment?
Rosendaal FR; Srámek R; Srámek A
Thromb Haemost; 1994 Jan; 71(1):157-8. PubMed ID: 8165639
[No Abstract] [Full Text] [Related]
2. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
Fonseca RJ; Mourão PA
Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
[TBL] [Abstract][Full Text] [Related]
3. Investigation on recombinant hirudin via oral route.
Cen X; Ni J; Tan T; Liu X; Li C; Chen J; Huang Y; Zhu S; Bi Q
Peptides; 2006 Apr; 27(4):836-40. PubMed ID: 16469415
[TBL] [Abstract][Full Text] [Related]
4. [Monitoring of oral anticoagulant therapy in Norway--recommendations for transfer to the INR system].
Sandset PM
Tidsskr Nor Laegeforen; 1998 Sep; 118(22):3443-5. PubMed ID: 9800495
[No Abstract] [Full Text] [Related]
5. Bleeding time and oral anticoagulant therapy.
Marongiu F; Biondi G; Sorano GG; Mameli G; Conti M; Mamusa AM; Balestrieri A
Thromb Haemost; 1993 May; 69(5):523-4. PubMed ID: 8357429
[No Abstract] [Full Text] [Related]
6. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
Crowther MA
Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
[TBL] [Abstract][Full Text] [Related]
7. Management of oral anticoagulant treatment in patients with venous thromboembolism.
Pengo V
Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
[TBL] [Abstract][Full Text] [Related]
8. Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases.
Turpie AG
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1238-47. PubMed ID: 17379841
[TBL] [Abstract][Full Text] [Related]
9. [Adverse reactions of coumarin derivative interactions].
Wiela-Hojeńska A; Orzechowska-Juzwenko K
Pol Merkur Lekarski; 2000 Sep; 9(51):600-1. PubMed ID: 11126983
[TBL] [Abstract][Full Text] [Related]
10. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
Fairweather RB; Ansell J; van den Besselaar AM; Brandt JT; Bussey HI; Poller L; Triplett DA; White RH
Arch Pathol Lab Med; 1998 Sep; 122(9):768-81. PubMed ID: 9740135
[TBL] [Abstract][Full Text] [Related]
11. A step change in oral anticoagulation: lack of coagulation monitoring with ximelagatran.
Carlsson SC; Schulman S
Semin Vasc Med; 2005 Aug; 5(3):259-65. PubMed ID: 16123913
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
